You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid Cancers

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Gut Microbiome and Immunotherapy Response in Solid Cancers

Recruiting
  • Cancer
    • Galveston, Texas
      University of Texas Medical Branch
    Sep 15, 2023

    Solid Tumor, Adult Trial in Beijing (Vaccine)

    Not yet recruiting
    • Solid Tumor, Adult
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Aug 3, 2023

    Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

    Active, not recruiting
    • Metastatic Cancer
    • HER2 Gene Mutation
    • Neratinib Maleate
    • Seoul, Korea, Republic of
      Korea university Guro hospital
    Oct 18, 2023

    Solid Tumor Trial in Adelaide (Radvax)

    Recruiting
    • Solid Tumor
    • Radvax
    • Adelaide, South Australia, Australia
      ARASMI
    Apr 8, 2023

    Solid Carcinoma Trial (fecal microbiota transplantation with Nivolumab)

    Not yet recruiting
    • Solid Carcinoma
    • fecal microbiota transplantation with Nivolumab
    • (no location specified)
    Sep 14, 2022

    Advanced Solid Cancers Trial in Tainan (ADI PEG20, Pembrolizumab)

    Terminated
    • Advanced Solid Cancers
    • Tainan, Taiwan
      Facility National Cheng Kung University
    Apr 20, 2022

    Advanced Solid Tumor, Triple Negative Breast Cancer Trial (Pembrolizumab & ADG106 (Phase Ib), Pembrolizumab & ADG106 (Phase II))

    Not yet recruiting
    • Advanced Solid Tumor
    • Triple Negative Breast Cancer
    • Pembrolizumab & ADG106 (Phase Ib)
    • Pembrolizumab & ADG106 (Phase II)
    • (no location specified)
    Aug 5, 2022

    Epithelial Ovarian Cancer, Triple Negative Breast Cancer, Non-squamous Non-small-cell Lung Cancer Trial in Paris, Rennes, Milano

    Recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • NI-1801
    • Paris, France
    • +4 more
    Nov 4, 2022

    Solid Tumors Trial in Boynton Beach (White Blood Cells/Granulocytes)

    Enrolling by invitation
    • Solid Tumors
    • White Blood Cells/Granulocytes
    • Boynton Beach, Florida
      South Florida Bone Marrow / Stem Cell Transplant Institute
    May 5, 2022

    Locally Advanced Malignant Solid Tumor Trial in Houston (Pembrolizumab)

    Recruiting
    • Locally Advanced Malignant Solid Neoplasm
    • Pembrolizumab
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 22, 2022

    Tumor Trial in Chuo-Ku, Kashiwa (JNJ-63723283, Erdafitinib)

    Completed
    • Neoplasm
    • Chuo-Ku, Japan
    • +1 more
    Nov 3, 2022

    Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

    Recruiting
    • Gastric Cancer
    • +9 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Fludarabine + Cyclophosphamide combination
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 21, 2022

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • Metastatic Malignant Solid Neoplasm
    • Biopsy
    • +3 more
    • (no location specified)
    Jan 18, 2023

    Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

    Not yet recruiting
    • Advanced Solid Tumor
    • Metastatic Solid Tumor
    • (no location specified)
    Aug 5, 2022

    Cancer, Solid Tumor Trial in Houston (drug, biological, diagnostic test)

    Completed
    • Cancer
    • Solid Tumor
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 14, 2022

    Testing Practices for Common Solid Cancers in Precision Oncology

    Active, not recruiting
    • Breast Carcinoma
    • +5 more
    • Survey Administration
    • Chicago, Illinois
      Center for Business Models in Healthcare
    Dec 29, 2021

    Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

    Not yet recruiting
    • Anal Squamous Cell Carcinoma
    • +7 more
    • Regorafenib in combination with Tislelizumab
    • (no location specified)
    Oct 12, 2022

    European Reference Network on Rare Adult Solid Cancers

    Recruiting
    • Head and Neck Cancer
    • +4 more
    • observation
    • Brno, Czechia
    • +10 more
    Aug 1, 2022

    Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

    Not yet recruiting
    • Advanced Solid Tumor
    • Non-small Cell Lung Cancers
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 15, 2023

    Blood, Urine and Bone Marrow of Patients With Solid Cancers

    Recruiting
    • Non-small Cell Lung Cancer
    • +5 more
    • Study sample collection
    • Columbia, Missouri
      Ellis Fischel Cancer Center, University of Missouri
    Dec 1, 2021

    Metastasis, Solid Tumor Trial (Peptide Alarm Therapy (PAT))

    Not yet recruiting
    • Metastasis
    • Solid Tumor
    • Peptide Alarm Therapy (PAT)
    • (no location specified)
    Nov 2, 2022

    Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory

    Withdrawn
    • Advanced Malignant Neoplasm
    • +10 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 15, 2022

    Advanced Solid Tumor Trial (NXP900)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    May 15, 2023

    Blood, Urine, and Bone Marrow

    Recruiting
    • Non Small Cell Lung Cancer
    • +5 more
    • Test for circulating tumor cells, DNA alterations
    • Columbia, Missouri
      Harry S Truman Veterans Memorial Hospital
    Oct 31, 2022

    Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Extra-Pulmonary Small Cell Carcinomas
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023